Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2021-06-26 11:36 Tx date 2021-06-14 |
$AVC
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Renaissance Mercantile Corp. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
5,000,000 | ||
Filed 2021-06-26 11:35 Tx date 2021-06-14 |
$AVC
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
500,049 | ||
Filed 2021-06-24 17:54 Tx date 2021-06-14 |
$AVC
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-06-24 17:52 Tx date 2021-06-14 |
$AVC
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Renaissance Mercantile Corp. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-06-24 16:48 Tx date 2021-06-14 |
$AVC
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-06-24 15:00 Tx date 2021-06-14 |
$AVC
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-06-25 11:09 Tx date 2021-06-14 |
$AVC
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Williams, Mark
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
450,000 | ||
Filed 2021-06-25 11:05 Tx date 2021-06-14 |
$AVC
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Williams, Mark
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
5,000,049 | ||
Filed 2021-06-24 17:54 Tx date 2021-06-14 |
$AVC
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
500,000 | ||
Filed 2021-06-24 17:52 Tx date 2021-06-14 |
$AVC
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Renaissance Mercantile Corp. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
5,000,049 | ||
Filed 2021-06-24 17:38 Tx date 2021-06-14 |
$AVC
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Fehr, Jeremy David
4 - Director of Issuer
Holder: 1761595 Alberta Ltd (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
600,000 | ||
Filed 2021-06-24 17:36 Tx date 2021-06-14 |
$AVC
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Fehr, Jeremy David
4 - Director of Issuer
Holder: 1761595 Alberta Ltd (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
600,000 | ||
Filed 2021-06-24 16:48 Tx date 2021-06-14 |
$AVC
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
5,500,049 | ||
Filed 2021-06-24 16:48 Tx date 2021-06-14 |
$AVC
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-06-24 15:29 Tx date 2021-06-14 |
$AVC
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Groot, Jacqueline
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
275,000 | ||
Filed 2021-06-24 15:26 Tx date 2021-06-14 |
$AVC
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Groot, Jacqueline
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-06-24 15:20 Tx date 2021-06-14 |
$AVC
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
450,000 | ||
Filed 2021-06-24 15:00 Tx date 2021-06-14 |
$AVC
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-06-24 15:00 Tx date 2021-06-14 |
$AVC
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
500,000 | ||
Filed 2021-06-24 15:00 Tx date 2021-06-14 |
$AVC
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-06-24 13:04 Tx date 2021-06-14 |
$AVC
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Groot, Jacqueline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
650,000 | ||
Filed 2021-06-23 13:38 Tx date 2021-06-14 |
$AVC
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Maddin, Preston
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
350,000 | ||
Filed 2021-06-23 13:37 Tx date 2021-06-14 |
$AVC
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Maddin, Preston
5 - Senior Officer of Issuer
Holder: 1036735 Alberta Ltd. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
250,000 | ||
Filed 2021-06-23 13:35 Tx date 2021-06-14 |
$AVC
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Maddin, Preston
5 - Senior Officer of Issuer
Holder: 1036735 Alberta Ltd. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
400,000 | ||
Filed 2017-07-01 Tx date 2016-12-30 |
$AVC
American Vanadium Corp. |
Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
$-40,000
-100,000 vol $0.40 each |
0 | |
Filed 2017-07-01 Tx date 2016-04-23 |
$AVC
American Vanadium Corp. |
Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
$-12,857.16
-107,143 vol $0.12 each |
100,000 | |
Filed 2017-07-01 Tx date 2015-11-02 |
$AVC
American Vanadium Corp. |
Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-122,500
-175,000 vol $0.70 each |
1,100,000 | |
Filed 2017-06-19 Tx date 2017-06-15 |
$AVC
American Vanadium Corp. |
Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-37,000
-50,000 vol $0.74 each |
1,225,000 | |
Filed 2017-06-15 Tx date 2017-06-15 |
$AVC
American Vanadium Corp. |
Bayley, Brian Eric
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-37,000
-50,000 vol $0.74 each |
350,000 | |
Filed 2017-02-07 Tx date 2017-02-06 |
$AVC
American Vanadium Corp. |
Downes, John Graham
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-30,800
-40,000 vol $0.77 each |
190,000 | |
Filed 2016-09-19 Tx date 2016-09-15 |
$AVC
American Vanadium Corp. |
Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,000
+100,000 vol $0.02 each |
706,820 | |
Filed 2016-06-06 Tx date 2016-05-27 |
$AVC
American Vanadium Corp. |
Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,000
-200,000 vol $0.025 each |
606,820 | |
Filed 2016-06-06 Tx date 2016-05-27 |
$AVC
American Vanadium Corp. |
Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,000
-200,000 vol $0.03 each |
806,820 | |
Filed 2016-03-15 Tx date 2016-03-10 |
$AVC
American Vanadium Corp. |
Dundee Corporation
3 - 10% Security Holder of Issuer
Holder: Dundee Resources Limited (Indirect Ownership)
|
Warrants
55 - Expiration of warrants
|
-8,000,000 vol |
0 | |
Filed 2016-01-21 Tx date 2016-01-20 |
$AVC
American Vanadium Corp. |
Catell, Robert B.
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$11,242
+140,532 vol $0.08 each |
140,532 | |
Filed 2016-01-21 Tx date 2016-01-20 |
$AVC
American Vanadium Corp. |
Regberg Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
$66,480
+664,800 vol $0.10 each |
4,650,619 | |
Filed 2016-01-21 Tx date 2016-01-20 |
$AVC
American Vanadium Corp. |
Regberg Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$53,184
+664,800 vol $0.08 each |
8,136,439 | |
Filed 2016-01-21 Tx date 2016-01-20 |
$AVC
American Vanadium Corp. |
Catell, Robert B.
4 - Director of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
$14,053
+140,532 vol $0.10 each |
140,532 | |
Filed 2016-01-21 Tx date 2014-06-04 |
$AVC
American Vanadium Corp. |
Catell, Robert B.
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|